Johnson & Johnson (JNJ) discussion

1 conversation among FRC members — on Johnson & Johnson and on FRC's reports about it. Comments are members' own opinions, not investment advice.

From FRC

Before posting, ask yourself what another investor in Johnson & Johnsonwould learn from it. Questions, your own analysis and counterpoints are welcome — disagreement too. Keep it constructive, keep it respectful, and remember you're talking to real people.

House rules — not allowed

1Spam
Repetitive comments, mass-posting the same message across multiple reports, promotional links, referral codes, or comments that exist mainly to drive traffic elsewhere.
2Pump-and-dump language
Coordinated calls to buy/sell, price-target hype with no basis, or anything designed to manipulate other users' trading decisions.
3Personal attacks or harassment
Insults, threats, or targeting another user rather than their argument.
4Hate speech or discriminatory content
No exceptions.
5Impersonation
Pretending to be an FRC analyst, another user, or a company representative.
6Doxxing
Sharing anyone's private/personal information without consent.
7Illegal content
Anything that violates applicable law.
8Off-topic or low-effort spam
Comments unrelated to the report/discussion, or repeated low-value posts (e.g., rocket emoji spam with no substance).

Comments reflect the views of individual users, not FRC. Nothing posted in the comments section — by users or otherwise — should be taken as investment advice. Posts that break these rules may be removed without prior notice.

Comments on Johnson & Johnson (1)